Monopar Therapeutics Inc. logo

Monopar Therapeutics Inc. (MNPR)

Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
111. 12
+2.6
+2.3959%
$
714.12M Market Cap
- P/E Ratio
- Div Yield
265,200 Volume
-0.65 Eps
$ 108.52
Previous Close
Analysts:
Add Transaction
Day Range
104 111.94
Year Range
29.18 112.57
Want to track MNPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Monopar Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Joseph Castro
Joseph Castro Nuveen LLC
5,551 $431,577.93 $569,941.71 $138,363.78 32.06%
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
25 $1,632.5 $2,706.46 $1,073.96 65.79%
IM
Ilko Menkov Vestal Point Capita LLP
65,418 $3.58M $7.14M $3.56M 99.23%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
270,118 $17.03M $28.84M $11.81M 69.33%
Erik Roemer
Erik Roemer GERBER, LLC
5,601 $203,932 $599,867.1 $395,935.1 194.15%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
1,630 $89,308 $176,072.6 $86,764.6 97.15%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
964 $34,492 $102,535.86 $68,043.86 197.27%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
783 $42,900 $83,322.94 $40,422.94 94.23%
KGL
Kilter Group LLC Kilter Group LLC
1 $55 $107.2 $52.2 94.91%